As the European Union (EU) plots its spending plans for the next decade, global health organisations have made the case for continued European investment in the development of vaccines for so-called neglected diseases, such as dengue fever, malaria and tuberculosis.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.